United States Animal Blood Plasma and Derivatives Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Animal Blood Plasma and Derivatives Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Animal Blood Plasma and Derivatives Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Animal Blood Plasma and Derivatives Overall Market Size
2.1 United States Animal Blood Plasma and Derivatives Market Size: 2021 VS 2027
2.2 United States Animal Blood Plasma and Derivatives Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Animal Blood Plasma and Derivatives Players in United States Market
3.2 Top United States Animal Blood Plasma and Derivatives Companies Ranked by Revenue
3.3 United States Animal Blood Plasma and Derivatives Revenue by Companies
3.4 Top 3 and Top 5 Animal Blood Plasma and Derivatives Companies in United States Market, by Revenue in 2020
3.5 Companies Animal Blood Plasma and Derivatives Product Type
3.6 Tier 1, Tier 2 and Tier 3 Animal Blood Plasma and Derivatives Players in United States Market
3.6.1 List of Tier 1 Animal Blood Plasma and Derivatives Companies in United States
3.6.2 List of Tier 2 and Tier 3 Animal Blood Plasma and Derivatives Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Animal Blood Plasma and Derivatives Market Size Markets, 2021 & 2027
4.1.2 Immunoglobulin
4.1.3 Fibrinogen
4.1.4 Serum Albumin
4.1.5 Fetal Bovine Serum
4.1.6 Thrombin
4.1.7 New Born Calf Serum
4.2 By Type - United States Animal Blood Plasma and Derivatives Revenue & Forecasts
4.2.1 By Type - United States Animal Blood Plasma and Derivatives Revenue, 2016-2021
4.2.2 By Type - United States Animal Blood Plasma and Derivatives Revenue, 2022-2027
4.2.3 By Type - United States Animal Blood Plasma and Derivatives Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Animal Blood Plasma and Derivatives Market Size, 2021 & 2027
5.1.2 Food & Beverages
5.1.3 Pharmaceuticals
5.1.4 Cosmetics
5.1.5 Feed
5.1.6 Others
5.2 By Application - United States Animal Blood Plasma and Derivatives Revenue & Forecasts
5.2.1 By Application - United States Animal Blood Plasma and Derivatives Revenue, 2016-2021
5.2.2 By Application - United States Animal Blood Plasma and Derivatives Revenue, 2022-2027
5.2.3 By Application - United States Animal Blood Plasma and Derivatives Revenue Market Share, 2016-2027
6 Animal Blood Plasma and Derivatives Companies Profiles
6.1 Proliant Inc.
6.1.1 Proliant Inc. Company Details
6.1.2 Proliant Inc. Business Overview
6.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Introduction
6.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.1.5 Proliant Inc. Recent Developments
6.2 Thermo Fisher Scientific, Inc.
6.2.1 Thermo Fisher Scientific, Inc. Company Details
6.2.2 Thermo Fisher Scientific, Inc. Business Overview
6.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Introduction
6.2.4 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.2.5 Thermo Fisher Scientific, Inc. Recent Developments
6.3 Merck KGaA
6.3.1 Merck KGaA Company Details
6.3.2 Merck KGaA Business Overview
6.3.3 Merck KGaA Animal Blood Plasma and Derivatives Introduction
6.3.4 Merck KGaA Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.3.5 Merck KGaA Recent Developments
6.4 Kraeber & Co GmbH
6.4.1 Kraeber & Co GmbH Company Details
6.4.2 Kraeber & Co GmbH Business Overview
6.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Introduction
6.4.4 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.4.5 Kraeber & Co GmbH Recent Developments
6.5 LAMPIRE Biological Laboratories, Inc.
6.5.1 LAMPIRE Biological Laboratories, Inc. Company Details
6.5.2 LAMPIRE Biological Laboratories, Inc. Business Overview
6.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Introduction
6.5.4 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.5.5 LAMPIRE Biological Laboratories, Inc. Recent Developments
6.6 Lake Immunogenics, Inc.
6.6.1 Lake Immunogenics, Inc. Company Details
6.6.2 Lake Immunogenics, Inc. Business Overview
6.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Introduction
6.6.4 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.6.5 Lake Immunogenics, Inc. Recent Developments
6.7 Rocky Mountain Biologicals Inc.
6.7.1 Rocky Mountain Biologicals Inc. Company Details
6.7.2 Rocky Mountain Biologicals Inc. Business Overview
6.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Introduction
6.7.4 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.7.5 Rocky Mountain Biologicals Inc. Recent Developments
6.8 ANZCO Foods Ltd.
6.8.1 ANZCO Foods Ltd. Company Details
6.8.2 ANZCO Foods Ltd. Business Overview
6.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Introduction
6.8.4 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.8.5 ANZCO Foods Ltd. Recent Developments
6.9 Auckland BioSciences Ltd.
6.9.1 Auckland BioSciences Ltd. Company Details
6.9.2 Auckland BioSciences Ltd. Business Overview
6.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Introduction
6.9.4 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.9.5 Auckland BioSciences Ltd. Recent Developments
6.10 Bovogen Biologicals Pty Ltd.
6.10.1 Bovogen Biologicals Pty Ltd. Company Details
6.10.2 Bovogen Biologicals Pty Ltd. Business Overview
6.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Introduction
6.10.4 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021)
6.10.5 Bovogen Biologicals Pty Ltd. Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Animal Blood Plasma and Derivatives Market Opportunities & Trends in United States Market
Table 2. Animal Blood Plasma and Derivatives Market Drivers in United States Market
Table 3. Animal Blood Plasma and Derivatives Market Restraints in United States Market
Table 4. Key Players of Animal Blood Plasma and Derivatives in United States Market
Table 5. Top Animal Blood Plasma and Derivatives Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Animal Blood Plasma and Derivatives Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Animal Blood Plasma and Derivatives Revenue Share by Companies, 2016-2021
Table 8. Companies Animal Blood Plasma and Derivatives Product Type
Table 9. List of Tier 1 Animal Blood Plasma and Derivatives Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Animal Blood Plasma and Derivatives Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Animal Blood Plasma and Derivatives Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Animal Blood Plasma and Derivatives Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Animal Blood Plasma and Derivatives Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Animal Blood Plasma and Derivatives Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Animal Blood Plasma and Derivatives Revenue (US$, Mn), 2022-2027
Table 17. Proliant Inc. Company Details
Table 18. Proliant Inc. Business Overview
Table 19. Proliant Inc. Animal Blood Plasma and Derivatives Product
Table 20. Proliant Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Proliant Inc. Recent Developments
Table 22. Thermo Fisher Scientific, Inc. Company Details
Table 23. Thermo Fisher Scientific, Inc. Business Overview
Table 24. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product
Table 25. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Thermo Fisher Scientific, Inc. Recent Developments
Table 27. Merck KGaA Company Details
Table 28. Merck KGaA Business Overview
Table 29. Merck KGaA Animal Blood Plasma and Derivatives Product
Table 30. Merck KGaA Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Merck KGaA Recent Developments
Table 32. Kraeber & Co GmbH Company Details
Table 33. Kraeber & Co GmbH Business Overview
Table 34. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product
Table 35. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Kraeber & Co GmbH Recent Developments
Table 37. LAMPIRE Biological Laboratories, Inc. Company Details
Table 38. LAMPIRE Biological Laboratories, Inc. Business Overview
Table 39. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product
Table 40. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. LAMPIRE Biological Laboratories, Inc. Recent Developments
Table 42. Lake Immunogenics, Inc. Company Details
Table 43. Lake Immunogenics, Inc. Business Overview
Table 44. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product
Table 45. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Lake Immunogenics, Inc. Recent Developments
Table 47. Rocky Mountain Biologicals Inc. Company Details
Table 48. Rocky Mountain Biologicals Inc. Business Overview
Table 49. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product
Table 50. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Rocky Mountain Biologicals Inc. Recent Developments
Table 52. ANZCO Foods Ltd. Company Details
Table 53. ANZCO Foods Ltd. Business Overview
Table 54. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product
Table 55. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. ANZCO Foods Ltd. Recent Developments
Table 57. Auckland BioSciences Ltd. Company Details
Table 58. Auckland BioSciences Ltd. Business Overview
Table 59. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product
Table 60. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Auckland BioSciences Ltd. Recent Developments
Table 62. Bovogen Biologicals Pty Ltd. Company Details
Table 63. Bovogen Biologicals Pty Ltd. Business Overview
Table 64. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product
Table 65. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Bovogen Biologicals Pty Ltd. Recent Developments
List of FiguresFigure 1. Animal Blood Plasma and Derivatives Segment by Type
Figure 2. Animal Blood Plasma and Derivatives Segment by Application
Figure 3. United States Animal Blood Plasma and Derivatives Market Overview: 2020
Figure 4. United States Animal Blood Plasma and Derivatives Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Animal Blood Plasma and Derivatives Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2020
Figure 7. By Type - United States Animal Blood Plasma and Derivatives Revenue Market Share, 2016-2027
Figure 8. By Application - United States Animal Blood Plasma and Derivatives Revenue Market Share, 2016-2027
Figure 9. Proliant Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Merck KGaA Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)